FI954614A0 - Imidatsolokinoksalinonijohdannaiset EAA-antagonisteina - Google Patents

Imidatsolokinoksalinonijohdannaiset EAA-antagonisteina

Info

Publication number
FI954614A0
FI954614A0 FI954614A FI954614A FI954614A0 FI 954614 A0 FI954614 A0 FI 954614A0 FI 954614 A FI954614 A FI 954614A FI 954614 A FI954614 A FI 954614A FI 954614 A0 FI954614 A0 FI 954614A0
Authority
FI
Finland
Prior art keywords
imidazoloquinoxalinone
derivatives
preparation
eaa antagonists
eaa
Prior art date
Application number
FI954614A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI954614A (fi
Inventor
Hans-Joerg Treiber
Berthold Behl
Hans-Peter Hofmann
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4329970A external-priority patent/DE4329970A1/de
Application filed by Basf Ag filed Critical Basf Ag
Publication of FI954614A publication Critical patent/FI954614A/fi
Publication of FI954614A0 publication Critical patent/FI954614A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, ***e

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI954614A 1993-03-31 1995-09-28 Imidatsolokinoksalinonijohdannaiset EAA-antagonisteina FI954614A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4310521 1993-03-31
DE4329970A DE4329970A1 (de) 1993-03-31 1993-09-04 Neue Imidazolo-chinoxalinone, ihre Hestellung und Verwendung
PCT/EP1994/000871 WO1994022865A1 (de) 1993-03-31 1994-03-19 Imidazolochinoxalinonderivate als eaa antagonisten

Publications (2)

Publication Number Publication Date
FI954614A FI954614A (fi) 1995-09-28
FI954614A0 true FI954614A0 (fi) 1995-09-28

Family

ID=25924528

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954614A FI954614A0 (fi) 1993-03-31 1995-09-28 Imidatsolokinoksalinonijohdannaiset EAA-antagonisteina

Country Status (17)

Country Link
EP (1) EP0691970B1 (no)
JP (1) JPH08508271A (no)
CN (1) CN1041928C (no)
AT (1) ATE173263T1 (no)
AU (1) AU6428294A (no)
BR (1) BR9406034A (no)
CA (1) CA2158167A1 (no)
CZ (1) CZ246495A3 (no)
FI (1) FI954614A0 (no)
HR (1) HRP940210A2 (no)
HU (1) HUT73970A (no)
IL (1) IL109076A (no)
NO (1) NO953892L (no)
NZ (1) NZ263552A (no)
PL (1) PL310950A1 (no)
SI (1) SI9420023A (no)
WO (1) WO1994022865A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE214069T1 (de) * 1994-02-11 2002-03-15 Novo Nordisk As Heterocyclische verbindungen und ihre herstellung und verwendung
FR2722789B1 (fr) * 1994-07-20 1996-08-23 Rhone Poulenc Rorer Sa Derives d'acide imidazo (1,2-a)indeno(1,2-e) pyrazine-2-carboxylique, leur preparation et les medicaments les contenant
IT1276167B1 (it) * 1995-11-24 1997-10-27 Foscama Biomed Chim Farma Imidazo(1,2-alfa)chinossalin-4-ammine attivi come antagonisti adenosinici,procedimento per la loro preparazione e loro composizioni
FR2743363A1 (fr) * 1996-01-10 1997-07-11 Rhone Poulenc Rorer Sa 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-a-ones substituees en position 2, leur preparation et les medicaments les contenant
US6271418B1 (en) * 2000-02-22 2001-08-07 Nippon Kayaku Co., Ltd. Process for preparing (hetero) aromatic substituted benzene derivatives
GB0017518D0 (en) 2000-07-17 2000-08-30 Merck Sharp & Dohme Therapeutic agents
GB0018473D0 (en) * 2000-07-27 2000-09-13 Merck Sharp & Dohme Therapeutic agents
CN100386326C (zh) * 2003-10-22 2008-05-07 中国人民解放军军事医学科学院毒物药物研究所 1-羟甲基咪唑并[1,2-a]喹喔啉化合物及其应用
CA2671980C (en) 2006-12-13 2015-05-05 Aska Pharmaceutical Co., Ltd. Quinoxaline derivatives
FR2921927B1 (fr) * 2007-10-03 2012-10-12 Univ De Montpellier 1 Imidazo°1,2-a!quinoxalines et derives pour le traitement des cancers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2043064B (en) * 1979-02-09 1983-04-13 Roussel Lab Ltd Oximidazoquinoxaline derivatives
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
US5182386A (en) * 1991-08-27 1993-01-26 Neurogen Corporation Certain imidazoquinoxalinones; a new class of gaba brain receptor ligands

Also Published As

Publication number Publication date
IL109076A0 (en) 1994-06-24
PL310950A1 (en) 1996-01-08
CN1041928C (zh) 1999-02-03
EP0691970B1 (de) 1998-11-11
NZ263552A (en) 1997-06-24
HUT73970A (en) 1996-10-28
HRP940210A2 (en) 1996-12-31
FI954614A (fi) 1995-09-28
CZ246495A3 (en) 1996-03-13
JPH08508271A (ja) 1996-09-03
IL109076A (en) 1997-06-10
SI9420023A (en) 1996-04-30
NO953892D0 (no) 1995-09-29
CN1120336A (zh) 1996-04-10
AU6428294A (en) 1994-10-24
EP0691970A1 (de) 1996-01-17
NO953892L (no) 1995-09-29
WO1994022865A1 (de) 1994-10-13
BR9406034A (pt) 1996-01-02
ATE173263T1 (de) 1998-11-15
HU9502848D0 (en) 1995-11-28
CA2158167A1 (en) 1994-10-13

Similar Documents

Publication Publication Date Title
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
IS4073A (is) Nýtt fjölvirknislyf gegn aukningu mótstöðu
NO923975D0 (no) 2-aminometyl-kroman
DK0585328T3 (da) Substituerede 3-aminoquinuclidiner
PL398445A1 (pl) Kompozycje farmaceutyczne zawierające dekstrometorfan i chininę do leczenia zaburzeń neurologicznych
MY130145A (en) Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders.
MY110110A (en) Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders
NO306779B1 (no) Naftalamider, anvendelse derav og farmasöytisk preparat
GEP20104959B (en) Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
DE69807587D1 (de) Quinazolin-4-on AMPA Antagonisten
FI954614A0 (fi) Imidatsolokinoksalinonijohdannaiset EAA-antagonisteina
BR9803385A (pt) AtropisÈmeros de 2,3-dissubstituìdo-(5,6)-heteroaril condensado-pirimidin-4-onas.
HUP0100611A2 (hu) Triazin vegyületek, és ilyeneket tartalmazó gyógyszerkészítmények a központi idegrendszer elváltozásainak kezelésére
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
NO982863L (no) Nye forbindelser med analgetisk effekt
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
TR199901385T2 (xx) Piperidin t�revleri.
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central
PT950053E (pt) Novos derivados de benzoilalquil-1,2,3,6-tetra-hidropiridinas
TR200101476T2 (tr) N-ikameli azabisikloaklan türevlerinin merkezi sinir sistemi bozukluklarının tedavisinde kullanılması
TR200000916T2 (tr) İkameli piperidin türevleri.
IE45454L (en) Cns-active compositions

Legal Events

Date Code Title Description
FD Application lapsed